Skip to main content
SpringerLink
Log in

Deep Vein Thrombosis in Intensive Care

  • Chapter
  • First Online:
Thrombosis and Embolism: from Research to Clinical Practice

Part of the book series: Advances in Experimental Medicine and Biology ((AIM,volume 906))

Abstract

Venous thromboembolism (VTE) which includes deep vein thrombosis (DVT) and pulmonary embolism (PE) is a severe complication in critically ill patients generally affected by multiorgan disfunction associated with immobilization also prolonged.

Nowadays, VTE prophylaxis is included in the requirements of hospital accreditation and evaluation of the maintenance of standards of quality of care. ICU patients are characterized by a dynamic day-to-day variation both of thromboembolic that bleeding risk and DVT incidence in presence of thromboprophylaxis ranges between 5 and 15 %.

Patient-centered methods for the assessment of both thrombotic and bleeding risk are recommended because pre-existent factors to ICU admission, diagnosis, emerging syndromes, invasive procedures and pharmacological treatments daily induce important changes in clinical condition.

General consensus currently establishes use of heparin in pharmacological prophylaxis at the time of admission to the ICU and the temporary suspension of heparin in patients with active bleeding or severe (<50,000/cc) thrombocytopenia. Individualized thromboprophylaxis regimens were proposed but there is still no consensus based on evidence.

DVT diagnosis is not clinical but imaging-based and in each ICU data on DVT incidence (DVT diagnosed 72 h after ICU admission) should be obtained by weekly ultrasound screening standardized for the anatomical sites of compression used, taking into account the persistence of DVT-risk throughout ICU stay. A role for mechanical thromboprophylaxis by elastic stockings or pneumatic compression was reported but no general consensus was reached about its use at the best. Much work has to be done but ICU remain the last frontier for VTE prophylaxis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Geerts W, Selby R (2003) Prevention of venous thromboembolism in the ICU. Chest 124(6 Suppl):357S

    Article  PubMed  Google Scholar 

  2. McLeod AG, Geerts W (2011) Venous thromboembolism prophylaxis in critically ill patients. Crit Care Clin 27(4):765–780

    Article  PubMed  Google Scholar 

  3. Cook D, Crowther M, Meade M et al (2005) Deep vein thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors. Crit Care Med 33(7):1565–1571

    Article  PubMed  Google Scholar 

  4. Boddi M, Barbani F, Abbate R, Bonizzoli M, Batacchi S, Lucente E, Chiostri M, Gensini GF, Peris A (2010) Reduction in deep vein thrombosis incidence in intensive care after a clinician education program. J Thromb Haemost 8:121–128

    Article  CAS  PubMed  Google Scholar 

  5. Moser KM, Le Moine JR, Natchwey FJ, Spragg RG (1981) Deep venous thrombosis and pulmonary embolism. Frequency in respiratory intensive care unit. JAMA 246(13):1422–1424

    Article  CAS  PubMed  Google Scholar 

  6. Cade JF (1982) High risk of the critically ill for venous thromboembolism. Crit Care Med 10(7):448–450

    Article  CAS  PubMed  Google Scholar 

  7. Kapoor M, Kupfer YY, Tessler S (1999) Subcutaneously heparin prophylaxis significantly reduces the incidence of venous thromboembolic events in critically ill. Crit Care Med 27(Suppl 12):A69

    Article  Google Scholar 

  8. Fraisse F, Holzapfel L, Couland JM et al (2000) The Association of Non-University Affiliated Intensive Care Specialist Physician of France. Naproparin in the prevention of deep vein thrombosis in acute decompensated COPD. Am J Respir Crit Care Med 161(4, Pt 1):1109–1114

    Article  CAS  PubMed  Google Scholar 

  9. Kahn SR, Lim W, Dunn AS, et al (2012) American College of chest physicians. Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed. American College of Chest Physicians. Evidence-Based Clinical Practice Guidelines. Chest 141(2, Suppl):e1955–e2265

    Google Scholar 

  10. Geerts WH, Pineo GF, Bergqvist D, Lassen CCW, Ray J (2004) Prevention of venous thromboembolism:the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126:338S–400S

    Article  CAS  PubMed  Google Scholar 

  11. Boonyawat K, Crowther MA (2015) Venous thromboembolism prophylaxis in critically ill patients. Semin Thromb Hemost 41:68–74

    Article  PubMed  Google Scholar 

  12. Wells PS, Owen C, Doucette S, Fergusson D, Tran H (2006) Does this patient have deep vein thrombosis? JAMA 295:199–207

    Article  CAS  PubMed  Google Scholar 

  13. Barbar S, Noventa F, Rossetto V, Ferrari A, Brandolin B, Perlati M et al (2010) A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost 8(11):2450–2457

    Article  CAS  PubMed  Google Scholar 

  14. Caprini JA, Arcelus JI, Reyna JJ (2001) Effective risk stratification of surgical and not surgical patients for venous thromboembolic disease. Semin Hematol 38:12S–19S

    Article  Google Scholar 

  15. Katsios CM, Donadini M, Meade M, Mehta S, Granton J, Kutsiogiannis J et al (2014) Prediction scores do not correlate with clinically adjudicated categories of pulmonary embolism in critically ill patients. Can Respir J 21(1):36–42

    Article  PubMed  PubMed Central  Google Scholar 

  16. Williamson DR, Albert M, Heels-Ansdell D, Arnold DM, Lauzier F, Zarychanski R et al (2013) Thrombocytopenia in critically ill patients receiving thromboprophylaxis. Chest 144(4):1207–1215

    Article  PubMed  Google Scholar 

  17. Lauzier F, Arnold DM, Rabbat C, Heels-Ansdell D, Zarychanski R, Dodek P et al (2013) Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis. Intensive Care Med 39:2135–2143

    Article  CAS  PubMed  Google Scholar 

  18. Crowther MA, Cook DJ, Griffith LE, Devereaux PJ, Rabbat CC, Clarke FJ, Hoad N, McDonald E, Meade MO, Guyatt GH, Geerts WH, Wells PS (2005) Deep venous thrombosis: clinically silent in the intensive care unit. J Crit Care 20(4):334–340

    Article  PubMed  Google Scholar 

  19. Kearon C, Ginsberg JS, Hirsh J (1998) The role of venous ultrasonography in the diagnosis of suspected deep vein thrombosis and pulmonary embolism. Ann Intern Med 129:1044–1049

    Article  CAS  PubMed  Google Scholar 

  20. Blann AD, Lip GYH (2006) Venous thromboembolism. BMJ 332:215–219

    Article  PubMed  PubMed Central  Google Scholar 

  21. Shellong SM, Beyer J, Kakkar AK, Halbritter K, Eriksson BI, Turpie ACG et al (2007) Ultrasound screening for asymptomatic deep vein thrombosis after major orthopedic surgery: the VENUS study. J Thromb Haemost 5:1431–1437

    Article  Google Scholar 

  22. Cook DJ, Rocker G, Meade M, Guyatt G, Geerts WH (2005) Andersond, et al. PROTECT Investigators; Canadian Critical Care Trials Group. Prophylaxis of Thromboembolism in Critical Care (PROTECT) Trial: a pilot sudy. J Crit Care 20:364–372

    Article  PubMed  Google Scholar 

  23. Hirsch DR, Ingenito EP, Goldhaber SZ (1995) Prevalence of deep venous thrombosis among patients in medical intensive care. JAMA 274:335–337

    Article  CAS  PubMed  Google Scholar 

  24. The Intensive Care Society (2008) Guidelines for Venous Thromboprophylaxis in Critical Care. http://www.ics.ac.uk/icmprof/downloads/2008102336_Thromboprophylaxis%2027%2010%2008.pdf

  25. Pierce CA, Haut ER, Kardooni S, Chang DC, Efron DT, Haider A, Pronovost PJ (2008) Cornwell EE 3rd.Surveillance bias and deep vein thrombosis in the national trauma data bank; the more we look, the more we find. J Trauma 64:932–936

    Article  PubMed  Google Scholar 

  26. Boddi M, Cecchi A, Bonizzoli M, Barbani F, Franci A, Anichini V, Batacchi S, Parodo J, Gensini GF, Peris A (2014) Follow-up after four-year quality improvement program to prevent inferior limb deep vein thrombosis in intensive care unit. Thromb Res 134(3):578–583

    Article  CAS  PubMed  Google Scholar 

  27. Geerts W(1), Cook D, Selby R, Etchells E (2002) Venous thromboembolism and its prevention in critical care. J Crit Care 17(2):95–104

    Google Scholar 

  28. Bonizzoli M, Batacchi S, Cianchi G, Zagli G, Lapi F, Tucci V et al (2011) Peripherally inserted central venous catheters and central venous catheters related thrombosis in post-critical patients. Intensive Care Med 37(2):284–289

    Article  PubMed  Google Scholar 

  29. Lamontagne F, McIntyre L, Dodek P, Heels-Ansdell D, Meade M, Pemberton J et al (2014) Nonleg venous thrombosis in critically ill adults: a nested prospective cohort study FREE.JAMA. Intern Med 174(5):689–696

    Google Scholar 

  30. Migliaccio ML, Zagli G, Cianchi G, Lazzeri C, Bonizzoli M, Cecchi A, Anichini V, Gensini GF, Peris A (2013) Extracorporeal membrane oxygenation in brain-death organ and tissues donors: a single-centre experience. Br J Anaesth 111(4):673–674

    Article  CAS  PubMed  Google Scholar 

  31. Mammen EF (1992) Pathogenesis of venous thrombosis. Chest 102:640S–644S

    Article  CAS  PubMed  Google Scholar 

  32. Miranda AR, Hassouna HI (2000) Mechanisms of thrombosis in spinal cord injury. Hematol Oncol Clin North Am 14:401–416

    Article  CAS  PubMed  Google Scholar 

  33. Ibrahim EH, Irequi M, Prentice D, Sherman G, KollefMH SW (2002) Deep vein thrombosis during prolonged mechanical ventilation despite prophylaxis. Crit Care Med 30:771–774

    Article  PubMed  Google Scholar 

  34. Cook DJ, Crowther MA, Geerts WH (2005) On the need for a workshop on venous thromboembolism in critical care. J Crit Care 20(4):306–308

    Article  PubMed  Google Scholar 

  35. Garcia-Olivares P, Guerrero JE, Galdos P, Carriedo D, Murillo F (2014) Rivera A.PROF-ETEV study: prophylaxis of venous thromboembolic disease in critical care units in Spain. Intensive Care Med 40:1698–1708

    Article  PubMed  Google Scholar 

  36. Laporte S, Mismetti P (2010) Epidemiology of thrombotic risk factors:the difficulty of using clinical trials to develop a risk assessment model. Crit Care Med 38(2 Suppl):S10–S17

    Article  PubMed  Google Scholar 

  37. Welsby I, Ortel T (2015) Is the time for individualized thromboprophylaxis regimens in ICU? Crit Care Med 43:500–501

    Article  PubMed  Google Scholar 

  38. Alhazzani W, Lim W, Jaeschke RZ, Murad MH, Cade J, CooK DJ (2013) Heparin thromboprophylaxis in medical-surgical critically ill patients:a systematic review and meta-analysis of randomized trials. Crit Care Med 41(9):2088–2098

    Article  CAS  PubMed  Google Scholar 

  39. Rajasekhar A, Beyth R, Crowther MA (2012) Newer anticoagulants in critically ill patients. Crit Care Clin 28:427–451

    Article  PubMed  Google Scholar 

  40. De A, Roy P, Garg VK, Pandey NK (2010) Low-molecular-weight –heparin and unfractionated heparin in prophylaxis against deep vein thrombosis in critically ill patients undergoing major surgery. Blood Coagul Fibrinolysis 21(1):57–61

    Article  CAS  PubMed  Google Scholar 

  41. Cook D, Meade M, Guyatt G et al (2011) PROTECT Investigators for the Canadian Critical Care Trials Group and the Austalian and New Zeland Intensive Care Society Clinical Trials Group. Deltaparin versus unfractionated heparin in critically ill patients. N Engl J Med 364(14):1305–1314

    Article  CAS  PubMed  Google Scholar 

  42. Goldhaber SZ, Kett DH, Cusumano CJ et al (2000) Low molecular weight heparin versus minidose unfractionated heparin for prophylaxis against venous thromboembolism in medical intensive care unit patients: A randomized controlled trial. J Am Coll Cardiol 35(suppl):325 A

    Google Scholar 

  43. Lin W, Meade M, Lauzier F, Zarychanski R, Mehta S (2015) Lamontagne F for the PROTECT Trial Group. Failure of anticoagulant thromboprophylaxis:risk factors in medical-surgical critically ill patients. Crit Care Med 43:4001–4410

    Google Scholar 

  44. Beitland S, Sandven I, Kjærvik LK, Sandset PM, Sunde K, Eken T (2015) Thromboprophylaxis with low molecular weight heparin versus unfractionated heparin in intensive care patients: a systematic review with meta-analysis and trial sequential analysis. Intensive Care Med [Epub ahead of print]

    Google Scholar 

  45. Wang C, Chi C, Guo L, Wang X, Sun J, Liu S et al (2014) Heparin therapy reduces 28-day mortality in adult severe sepsis patients: a systematic review and meta-analysis. Crit Care 18:563–572

    Article  PubMed  PubMed Central  Google Scholar 

  46. Severinsen MT, Kristensen SR, Johensen SP et al (2009) Anthropometry, body fat, and venous thromboembolism.A Danish follow-up study. Circulation 120:1850–1857

    Article  PubMed  Google Scholar 

  47. Decousus H, Tapson VF, Bergmann JF, Chong BH, Froehlich JB, Kakkar AK (2011) Factors at admission associated with Bleeding risk in medical patients.Findings from the IMROVE Investigators. Chest 139:69–79

    Article  PubMed  Google Scholar 

  48. Cohen AT, Spiro TE, Spyropoulos AC, MAGELLAN Steering Committee (2013) Rivaroxaban for thromboprophylaxis in acutely ill medical patients. N Engl J Med 368(20):1945–1946. doi:10.1056/NEJMc1303641

    CAS  PubMed  Google Scholar 

  49. Goldhaber SZ(1), Leizorovicz A, Kakkar AK, Haas SK, Merli G, Knabb RM, Weitz JI (2011) ADOPT trial investigators. N Engl J Med. 365(23):2167–2177. doi:10.1056/NEJMoa1110899

    Google Scholar 

  50. Vignon P, Dequin PF, Renault A et al (2013) Clinical Research in Intensive Care and Sepsis Group ( CRICS Group). Intermittent pneumatic compression to prevent venous thromboembolism in patients at high risk of bleeding hospitalized in intensive care units: the CIREA1 randomized trial. Intensive Care Med 39(5):872–880

    Article  PubMed  Google Scholar 

  51. Cipolle MD, Wojcik R, Seislove E, Waaser T, Pasquale MD (2002) The role of surveillance duplex scanning in preventing venous thromboembolism in trauma patients. J Trauma 52:453–462

    PubMed  Google Scholar 

  52. Zhang C, Zeng W, Zhou H et al (2011) The efficacy of intermittent pneumatic compression in the prevention of venous thromboembolism in medical critically ill patients. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 23(9):563–565

    PubMed  Google Scholar 

  53. Arabi YM, Khedr M, Dara SI et al (2013) Use of intermittent pneumatic compression and not graduated compression stockings is associated with lower incident VTE in critically ill patients: a multiple propensity score analysis. Chest 144(1):152–159

    Article  PubMed  Google Scholar 

  54. Sharif-Kashani B, Shahabi P, Raeissi S, Behzadnia N, Shoaraka A, Shahrivari M et al (2012) ProphylAxis for VenouS ThromboembolIsm in hospitalized patients: the MASIH study. Clin Appl Thromb Hemost 18(5):462–468

    Article  PubMed  Google Scholar 

  55. Ho KM, Chavan S, Pilcher D (2011) Omission of early thromboprophylaxis and mortality in critically ill patients: a multi center registry study. Chest 140(6):51–57

    Article  Google Scholar 

  56. McMullin J, Cook D, Griffith L et al (2006) Minimizing errors of omission: behavioural re-enforcement of heparin to avoid venous emboli:the BEHAVE study. Crit Care Med 8(1):121–128

    Google Scholar 

  57. Teixera PG, Inaba K, Dubose J et al (2013) Measurable outcomes of quality improvement using a daily quality rounds checklist:two year prospective analysis of sustainability in a surgical intensive care unit. J Trauma Acute Care Surg 75(4):717–721

    Article  Google Scholar 

  58. Robinson S, Zincuk A, Larsen UL et al (2013) A comparative study of varying doses of enoxaparin for thromboprophylaxis in critically ill patients:A double-blinded, randomized controlled trial. Crit Care 17:R75–R79

    Article  PubMed  PubMed Central  Google Scholar 

  59. Crowther MA, Cook DJ (2008) Thromboprophylaxis in medical-surgical critically ill patients. Curr Opin Crit Care 14:520–523

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy

    Maria Boddi M.D., Ph.D.

  2. Trauma Emergency ICU, ECMO Referral Center, Careggi Teaching Hospital, Florence, Italy

    Adriano Peris M.D.

Authors
  1. Maria Boddi M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adriano Peris M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maria Boddi M.D., Ph.D. .

Editor information

Editors and Affiliations

  1. Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden

    Md. Shahidul Islam

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Boddi, M., Peris, A. (2016). Deep Vein Thrombosis in Intensive Care. In: Islam, M. (eds) Thrombosis and Embolism: from Research to Clinical Practice. Advances in Experimental Medicine and Biology(), vol 906. Springer, Cham. https://doi.org/10.1007/5584_2016_114

Download citation

  • DOI: https://doi.org/10.1007/5584_2016_114

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-22107-6

  • Online ISBN: 978-3-319-22108-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation